News
Windlas Biotech consolidated net profit declines 1.78% in the March 2026 quarter
21-May-2026 | 18:03
Sales rise 17.66% to Rs 238.50 crore
Net profit of Windlas Biotech declined 1.78% to Rs 15.99 crore in the quarter ended March 2026 as against Rs 16.28 crore during the previous quarter ended March 2025. Sales rose 17.66% to Rs 238.50 crore in the quarter ended March 2026 as against Rs 202.71 crore during the previous quarter ended March 2025.
For the full year,net profit rose 8.97% to Rs 66.46 crore in the year ended March 2026 as against Rs 60.99 crore during the previous year ended March 2025. Sales rose 18.98% to Rs 904.09 crore in the year ended March 2026 as against Rs 759.88 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 238.50 | 202.71 | 18 | 904.09 | 759.88 | 19 |
| OPM % | 10.60 | 12.60 | - | 11.59 | 12.38 | - |
| PBDT | 28.16 | 29.16 | -3 | 117.72 | 107.74 | 9 |
| PBT | 20.16 | 20.82 | -3 | 86.98 | 79.76 | 9 |
| NP | 15.99 | 16.28 | -2 | 66.46 | 60.99 | 9 |
Powered by Capital Market - Live News
